Herpes zoster virus of shingles
About us We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.
Read morePress releases
- GSK joins forces with the University of California to advance genomic research and improve drug discovery
- GSK announces data on anti-BCMA antibody-drug conjugate in patients with relapsed/refractory multiple myeloma to be presented at European Hematology Association (EHA) Congress
- Nucala (mepolizumab) gains FDA approval for two new self-administration options
Tweets from GSK
-
GSK @GSK
“Sometimes things in science do go wrong. And when things go wrong, it’s important to keep in mind the greater goal - which is to improve patients’ lives. And the stronger that goal, the wider my smile.” #MondayMotivation from Radu, one of our functional genomics investigators.
about 21 hours ago -
GSK @GSK
#ICYMI last week we announced a five-year collaboration with @UCBerkeley and @UCSF to establish a state-of-the-art laboratory for CRISPR technologies, the Laboratory for Genomics Research (LGR). Find out how we plan to accelerate the development of new medicines
about 23 hours ago -
GSK @GSK
Meet Jilcia Johnson and find out how her love of data and science influenced her career, and what role she played in helping us reach our latest data milestone for our investigatory treatment for people living with multiple myeloma: #FacesOfGSK #Innovation
about 1 day ago
